Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank29
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P29
Within normal range
vs 3Y Ago
-14.5x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM-96.73%-73.0%
2024-55.93%-265.1%
2023-15.32%-330.0%
20226.66%+100.4%
2021-1631.68%-120.3%
2020-740.56%-529.6%
2019-117.62%+10.6%
2018-131.50%-65.3%
2017-79.56%-1612.3%
2016-4.65%-